A Real-world Study of the Efficacy and Safety of Nimotuzumab in Combination With Chemoradiotherapy for LASCCHN

Clinical trial NCT04949503 · COMPLETED

Trial details

NCT number: NCT04949503
Sponsor: Biotech Pharmaceutical Co., Ltd.
Status: COMPLETED
Study type: OBSERVATIONAL

Locally Advanced Head and Neck Squamous Cell Carcinoma

Start date: 2021-10-08
Primary completion: 2023-03-15
Enrollment: 1931

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.